Clinical Trials Browser

Terminated × INDUSTRY × Solid Tumor × Clear all

NCT06487858 2026-05-11

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06094426 2026-04-29

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT05430360 2026-04-27

GT201

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05729399 2026-04-27

Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor

NCT05262530 2026-04-08

Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor

NCT07108140 2026-01-22

Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumor

NCT04617054 2026-01-21

Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion

Phase 2 Terminated

Other solid neoplasm

Solid Tumor

NCT06299761 2026-01-16

STARMAP

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06198426 2025-12-30

A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor

NCT03770494 2025-11-04

A Study of LY3405105 in Participants With Advanced Cancer

Phase 1 Terminated

54 enrolled 26 charts

Other solid neoplasm

Solid Tumor

NCT04242147 2025-09-16

A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04249843 2025-09-11

Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05707676 2025-09-11

MEETCD8-001

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04455620 2025-07-02

BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors

Phase 1/2 Terminated

49 enrolled 19 charts

Other solid neoplasm

Solid Tumor

NCT06535009 2025-06-04

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05192174 2025-05-23

Study of NIB101 in Participants With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04827576 2025-05-08

ELEVATELung&UC

Phase 2 Terminated

106 enrolled 22 charts

Other solid neoplasm

Solid Tumor

NCT05494762 2025-05-01

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04013217 2025-04-13

Evaluate Eribulin ORA in Subjects With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03592264 2024-10-15

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

Phase 1/2 Terminated

GastrointestinalOther solid neoplasm

Solid Tumor

NCT05581719 2024-04-17

A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor

NCT04675996 2024-02-08

First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03834220 2024-02-07

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

Phase 2 Terminated

63 enrolled 18 charts

Other solid neoplasm

Solid Tumor

NCT03928314 2023-12-15

Study of ORIC-101 in Combination With Anticancer Therapy

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT05120375 2023-10-11

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03139370 2023-08-25

Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03588039 2023-05-19

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03894540 2022-09-13

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase 1 Terminated

22 enrolled 27 charts

Other solid neoplasm

Solid Tumor

NCT03182673 2022-09-01

The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT04810208 2021-12-30

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03752177 2021-10-22

A Study of LY3415244 in Participants With Advanced Solid Tumors

Phase 1 Terminated

12 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT04111445 2021-09-10

Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03804515 2021-06-15

A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT02541604 2020-02-25

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

Phase 1/2 Terminated

87 enrolled 41 charts

Other solid neoplasm

Solid Tumor

NCT02737072 2019-08-12

A Study of LY2510924 and Durvalumab in Participants With Solid Tumors

Phase 1 Terminated

9 enrolled 13 charts

Other solid neoplasm

Solid Tumor

NCT02966171 2018-11-21

A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT02472977 2018-11-01

CXCessoR4

Phase 1/2 Terminated

61 enrolled 11 charts

Other solid neoplasm

Solid Tumor

NCT00982657 2015-11-20

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Phase 2 Terminated

34 enrolled 10 charts

Other solid neoplasm

Solid Tumor

NCT02049281 2015-02-10

A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)

Phase 1 Terminated

Other solid neoplasm

Solid Tumor